La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Grand Pharmaceutical Group Bilan de santé
Santé financière contrôle des critères 6/6
Grand Pharmaceutical Group possède un total de capitaux propres de HK$15.9B et une dette totale de HK$4.5B, ce qui porte son ratio d'endettement à 28.1%. Son actif total et son passif total sont HK$24.9B et de HK$9.0B. L'EBIT de Grand Pharmaceutical Group est HK$3.0B ce qui fait que son ratio de couverture des intérêts 17.8. Elle dispose de liquidités et de placements à court terme de HK$2.3B.
Informations clés
28.1%
Ratio d'endettement
HK$4.47b
Dette
| Ratio de couverture des intérêts | 17.8x |
| Argent liquide | HK$2.32b |
| Fonds propres | HK$15.90b |
| Total du passif | HK$9.00b |
| Total des actifs | HK$24.90b |
Mises à jour récentes de la santé financière
We Think Grand Pharmaceutical Group (HKG:512) Can Stay On Top Of Its Debt
Oct 20
Is Grand Pharmaceutical Group (HKG:512) A Risky Investment?
May 05Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly
Nov 21Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly
Aug 16Grand Pharmaceutical Group (HKG:512) Has A Rock Solid Balance Sheet
Mar 22These 4 Measures Indicate That Grand Pharmaceutical Group (HKG:512) Is Using Debt Safely
Dec 13Recent updates
Grand Pharmaceutical Group (HKG:512) Is Paying Out A Larger Dividend Than Last Year
Jun 05Market Participants Recognise Grand Pharmaceutical Group Limited's (HKG:512) Earnings
May 22Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26
Apr 25Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26
Mar 25We Think Grand Pharmaceutical Group (HKG:512) Can Stay On Top Of Its Debt
Oct 20Here's Why We Think Grand Pharmaceutical Group (HKG:512) Is Well Worth Watching
Sep 26Grand Pharmaceutical Group's (HKG:512) Dividend Will Be Increased To HK$0.14
Jun 04Is Grand Pharmaceutical Group (HKG:512) A Risky Investment?
May 05Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly
Nov 21Is Grand Pharmaceutical Group Limited (HKG:512) Trading At A 43% Discount?
Sep 05Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly
Aug 16Here's Why We Think Grand Pharmaceutical Group (HKG:512) Is Well Worth Watching
Jul 28Grand Pharmaceutical Group's (HKG:512) Dividend Will Be HK$0.11
May 29Is Grand Pharmaceutical Group Limited (HKG:512) Trading At A 45% Discount?
Apr 08Grand Pharmaceutical Group (HKG:512) Has A Rock Solid Balance Sheet
Mar 22If You Like EPS Growth Then Check Out Grand Pharmaceutical Group (HKG:512) Before It's Too Late
Jan 24These 4 Measures Indicate That Grand Pharmaceutical Group (HKG:512) Is Using Debt Safely
Dec 13Grand Pharmaceutical Group Limited's (HKG:512) Intrinsic Value Is Potentially 45% Above Its Share Price
Nov 27With EPS Growth And More, China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Is Interesting
Oct 25China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Seems To Use Debt Rather Sparingly
Sep 01Do China Grand Pharmaceutical and Healthcare Holdings's (HKG:512) Earnings Warrant Your Attention?
Jul 12We Think China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Can Stay On Top Of Its Debt
Apr 26Calculating The Fair Value Of China Grand Pharmaceutical and Healthcare Holdings Limited (HKG:512)
Apr 08Here's Why We Think China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Is Well Worth Watching
Mar 24Analyse de la situation financière
Passif à court terme: Les actifs à court terme de 512 ( HK$8.2B ) dépassent ses passifs à court terme ( HK$6.4B ).
Passif à long terme: Les actifs à court terme de 512 ( HK$8.2B ) dépassent ses passifs à long terme ( HK$2.6B ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de 512 ( 13.5% ) est considéré comme satisfaisant.
Réduire la dette: Le ratio d'endettement de 512 a été réduit de 29.4% à 28.1% au cours des 5 dernières années.
Couverture de la dette: La dette de 512 est bien couverte par le flux de trésorerie opérationnel ( 54.3% ).
Couverture des intérêts: Les paiements d'intérêts de 512 sur sa dette sont bien couverts par l'EBIT ( 17.8 x couverture).